VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+25.81%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$241M
AUM Growth
+$50.3M
(+26%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
4.82%
Top 10 Holdings %
Top 10 Hldgs %
9.37%
Holding
372
New
47
Increased
146
Reduced
160
Closed
17
Top Buys
| 1 |
Brookfield Renewable
BEPC
|
$1.83M |
| 2 |
Western Midstream Partners
WES
|
$1.11M |
| 3 |
Delek US
DK
|
$829K |
| 4 |
Viper Energy
VNOM
|
$789K |
| 5 |
Oneok
OKE
|
$751K |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$1.61M |
| 2 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$1.13M |
| 3 |
AIV
Aimco
AIV
|
$1.11M |
| 4 |
Telefônica Brasil
VIV
|
$1.01M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$988K |
Sector Composition
| 1 | Healthcare | 29.53% |
| 2 | Real Estate | 18.96% |
| 3 | Energy | 16.61% |
| 4 | Materials | 11.31% |
| 5 | Utilities | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KIO
151
KKR Income Opportunities Fund
KIO
$514M
| $411K | 0.17% |
28,471
-3,308
| -10% | -$47.8K |
|
152
Moderna
MRNA
$9.78B
| $410K | 0.17% |
3,925
-1,049
| -21% | -$110K |
|
|
BGB
153
Blackstone Strategic Credit 2027 Term Fund
BGB
$560M
| $409K | 0.17% |
32,737
-3,591
| -10% | -$44.9K |
|
154
Hercules Capital
HTGC
$3.49B
| $407K | 0.17% |
28,203
-12,839
| -31% | -$185K |
|
155
Goldman Sachs BDC
GSBD
$1.31B
| $402K | 0.17% |
21,032
-7,205
| -26% | -$138K |
|
156
WhiteHorse Finance
WHF
$204M
| $389K | 0.16% |
28,577
+8,408
| +42% | +$114K |
|
157
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $388K | 0.16% |
+4,442
| New | +$388K |
|
|
ADAP
158
Adaptimmune Therapeutics
ADAP
$10.9M
| $388K | 0.16% |
71,954
+40,945
| +132% | +$221K |
|
159
Gladstone Investment Corp
GAIN
$543M
| $382K | 0.16% |
37,841
-2,943
| -7% | -$29.7K |
|
160
Gladstone Capital
GLAD
$582M
| $377K | 0.16% |
21,287
+6,898
| +48% | +$122K |
|
161
TriplePoint Venture Growth BDC
TPVG
$275M
| $377K | 0.16% |
28,932
-7,396
| -20% | -$96.4K |
|
162
Xenon Pharmaceuticals
XENE
$3.02B
| $375K | 0.16% |
24,381
-1,292
| -5% | -$19.9K |
|
163
Ares Capital
ARCC
$15.8B
| $368K | 0.15% |
21,783
-7,861
| -27% | -$133K |
|
|
ODT
164
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $366K | 0.15% |
19,076
+10,941
| +134% | +$210K |
|
|
IMAB
165
I-MAB
IMAB
$358M
| $364K | 0.15% |
+7,725
| New | +$364K |
|
166
Sixth Street Specialty
TSLX
$2.32B
| $364K | 0.15% |
17,532
-5,874
| -25% | -$122K |
|
167
Golub Capital BDC
GBDC
$3.93B
| $362K | 0.15% |
25,618
-6,114
| -19% | -$86.4K |
|
168
Sangamo Therapeutics
SGMO
$165M
| $352K | 0.15% |
22,554
-5,495
| -20% | -$85.8K |
|
169
TG Therapeutics
TGTX
$5.11B
| $351K | 0.15% |
6,743
-11,178
| -62% | -$582K |
|
|
HARP
170
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $347K | 0.14% |
2,088
+340
| +19% | +$56.5K |
|
|
BSL
171
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$186M
| $346K | 0.14% |
24,352
-2,478
| -9% | -$35.2K |
|
172
SLR Investment Corp
SLRC
$911M
| $346K | 0.14% |
19,773
-2,601
| -12% | -$45.5K |
|
173
MeiraGTx Holdings
MGTX
$619M
| $345K | 0.14% |
22,763
-594
| -3% | -$9K |
|
174
BridgeBio Pharma
BBIO
$10.2B
| $343K | 0.14% |
4,820
-5,933
| -55% | -$422K |
|
|
ALLK
175
DELISTED
Allakos
ALLK
| $342K | 0.14% |
2,442
-2,109
| -46% | -$295K |
|